AS

Archana Shukla

Director Director DIN 08009044
DIN 08009044 First appointment Jan 2018 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Archana Shukla

Data last updated:

Archana Shukla was a Director at Winystra Pharmaceuticals Private Limited (2018–2023) and Director at Winystra Remedies Private Limited (from 2018). The companies operate in Trading.

DIN 08009044
Primary Designation Director
Industry Trading
First Appointment 09 Jan 2018
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Feb 20182018₹19 Lakh (FY 2025)Active
Winystra Remedies Private Limited U51909BR2018PTC036833
Director09 Jan 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Winystra Remedies Private Limited
Winystra Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Archana Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archana Shukla

Archana Shukla was first appointed on 09 Jan 2018 as Director at Winystra Remedies Private Limited.

Archana Shukla held 2 earlier board appointments: Winystra Pharmaceuticals Private Limited (Director, 23 Feb 2018 to 26 Jul 2023); Winystra Remedies Private Limited (Director, from 09 Jan 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available